
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
First-in-Human Study of the Radioligand 68Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma
Xiaojiang Duan, Lei Xia, Zhuochen Zhang, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 17, pp. 3395-3407
Open Access | Times Cited: 40
Xiaojiang Duan, Lei Xia, Zhuochen Zhang, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 17, pp. 3395-3407
Open Access | Times Cited: 40
Showing 1-25 of 40 citing articles:
The Journey of Antibody–Drug Conjugates: Lessons Learned from 40 Years of Development
Raffaele Colombo, Paolo Tarantino, Jamie R. Rich, et al.
Cancer Discovery (2024) Vol. 14, Iss. 11, pp. 2089-2108
Closed Access | Times Cited: 17
Raffaele Colombo, Paolo Tarantino, Jamie R. Rich, et al.
Cancer Discovery (2024) Vol. 14, Iss. 11, pp. 2089-2108
Closed Access | Times Cited: 17
Radiopharmaceuticals and their applications in medicine
Siqi Zhang, Xingkai Wang, Xin Gao, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 7
Siqi Zhang, Xingkai Wang, Xin Gao, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 7
Clinical Translation of a Dual-Integrin αvβ3- and CD13-Targeting PET Tracer
Xiao Zhang, Biao Yang, Chunxia Qin, et al.
Clinical Nuclear Medicine (2025)
Closed Access | Times Cited: 2
Xiao Zhang, Biao Yang, Chunxia Qin, et al.
Clinical Nuclear Medicine (2025)
Closed Access | Times Cited: 2
Therapeutic prospects of nectin-4 in cancer: applications and value
Kaiyue Li, Yujing Zhou, Maolin Zang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 13
Kaiyue Li, Yujing Zhou, Maolin Zang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 13
Spatial distribution and subtype‐specific expression patterns of Nectin‐4 in muscle‐invasive bladder cancer
Csilla Oláh, Lara Sichward, Boris Hadaschik, et al.
BJU International (2025)
Open Access | Times Cited: 1
Csilla Oláh, Lara Sichward, Boris Hadaschik, et al.
BJU International (2025)
Open Access | Times Cited: 1
Nuclear Medicine and Molecular Imaging in Urothelial Cancer: Current Status and Future Directions
Sandra McDonald, K.G. Keane, Richard Gauci, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 232-232
Open Access | Times Cited: 1
Sandra McDonald, K.G. Keane, Richard Gauci, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 232-232
Open Access | Times Cited: 1
Translational PET Imaging of Nectin-4 Expression in Multiple Different Cancers with68Ga-N188
Jianhua Zhang, Xiaojiang Duan, Xueqi Chen, et al.
Journal of Nuclear Medicine (2024) Vol. 65, Iss. Supplement 1, pp. 12S-18S
Open Access | Times Cited: 8
Jianhua Zhang, Xiaojiang Duan, Xueqi Chen, et al.
Journal of Nuclear Medicine (2024) Vol. 65, Iss. Supplement 1, pp. 12S-18S
Open Access | Times Cited: 8
Development of a 18F-Labeled Bicyclic Peptide Targeting EphA2 for Molecular Imaging of PSMA-Negative Prostate Cancer
Qianqian Gan, Kai Cui, Qi Cao, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 21, pp. 14623-14632
Closed Access | Times Cited: 11
Qianqian Gan, Kai Cui, Qi Cao, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 21, pp. 14623-14632
Closed Access | Times Cited: 11
The Role of Total-Body PET in Drug Development and Evaluation: Status and Outlook
Xiangxi Meng, Xiangxing Kong, Lei Xia, et al.
Journal of Nuclear Medicine (2024) Vol. 65, Iss. Supplement 1, pp. 46S-53S
Closed Access | Times Cited: 4
Xiangxi Meng, Xiangxing Kong, Lei Xia, et al.
Journal of Nuclear Medicine (2024) Vol. 65, Iss. Supplement 1, pp. 46S-53S
Closed Access | Times Cited: 4
Clinical Implementation of Total-Body PET in China
Yaping Wu, Tao Sun, Yee Ling Ng, et al.
Journal of Nuclear Medicine (2024) Vol. 65, Iss. Supplement 1, pp. 64S-71S
Closed Access | Times Cited: 4
Yaping Wu, Tao Sun, Yee Ling Ng, et al.
Journal of Nuclear Medicine (2024) Vol. 65, Iss. Supplement 1, pp. 64S-71S
Closed Access | Times Cited: 4
Exploring membranous NECTIN‐4 expression patterns and enfortumab vedotin response in prostate cancer
Richard Weiten, Marit Bernhardt, Max Niemann, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 14
Open Access | Times Cited: 4
Richard Weiten, Marit Bernhardt, Max Niemann, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 14
Open Access | Times Cited: 4
Development and preclinical characterization of a novel radiotheranostic EphA2-targeting bicyclic peptide
Mohamed El Fakiri, Anusha Regupathy, Lisa Uhlmann, et al.
Theranostics (2024) Vol. 14, Iss. 12, pp. 4701-4712
Open Access | Times Cited: 4
Mohamed El Fakiri, Anusha Regupathy, Lisa Uhlmann, et al.
Theranostics (2024) Vol. 14, Iss. 12, pp. 4701-4712
Open Access | Times Cited: 4
Advances in Preclinical Research of Theranostic Radiopharmaceuticals in Nuclear Medicine
Mei Hu, C. Zhang, Dandan Fan, et al.
ACS Applied Materials & Interfaces (2025)
Closed Access
Mei Hu, C. Zhang, Dandan Fan, et al.
ACS Applied Materials & Interfaces (2025)
Closed Access
A whole-body imaging technique for tumor-specific diagnostics and screening of B7-H3-targeted therapies
Lei Xia, Yan Wu, Yanan Ren, et al.
Journal of Clinical Investigation (2025)
Open Access
Lei Xia, Yan Wu, Yanan Ren, et al.
Journal of Clinical Investigation (2025)
Open Access
Targeted therapy in TNBC: Exploring the role of antibody-drug conjugates with a focus on sacituzumab govitecan
Nahida Siddiqui, Malavika Arun, K Aparna, et al.
Journal of Oncology Pharmacy Practice (2025)
Closed Access
Nahida Siddiqui, Malavika Arun, K Aparna, et al.
Journal of Oncology Pharmacy Practice (2025)
Closed Access
Pilot Study of Nectin-4–Targeted PET Imaging Agent68Ga-FZ-NR-1 in Triple-Negative Breast Cancer from Bench to First-in-Human
Li Sun, Yuyun Sun, Ke Zuo, et al.
Journal of Nuclear Medicine (2025), pp. jnumed.124.269024-jnumed.124.269024
Closed Access
Li Sun, Yuyun Sun, Ke Zuo, et al.
Journal of Nuclear Medicine (2025), pp. jnumed.124.269024-jnumed.124.269024
Closed Access
Emerging Paradigms in Genitourinary Cancers: Integrating Molecular Imaging, Hypoxia-Inducible Factor–Targeted Therapies, and Antibody-Drug Conjugates in Renal Cell and Urothelial Carcinomas
Rana R. McKay, Renu Eapen, Elizabeth Wulff‐Burchfield, et al.
American Society of Clinical Oncology Educational Book (2025) Vol. 45, Iss. 3
Closed Access
Rana R. McKay, Renu Eapen, Elizabeth Wulff‐Burchfield, et al.
American Society of Clinical Oncology Educational Book (2025) Vol. 45, Iss. 3
Closed Access
Management of Patients with Muscle-Invasive Bladder Cancer Achieving A Clinical Complete Response after Neoadjuvant Therapy: Evidence and Consideration for Active Surveillance
Benjamin I. Joffe, John R. Christin, Clémentine Le Coz, et al.
Current Urology Reports (2025) Vol. 26, Iss. 1
Closed Access
Benjamin I. Joffe, John R. Christin, Clémentine Le Coz, et al.
Current Urology Reports (2025) Vol. 26, Iss. 1
Closed Access
Development of Cyclic Peptide‐Based Radiotracers for uPAR
Xingkai Wang, Xu Zhang, Siqi Zhang, et al.
ChemMedChem (2025)
Closed Access
Xingkai Wang, Xu Zhang, Siqi Zhang, et al.
ChemMedChem (2025)
Closed Access
PET/Computed Tomography Transformation of Oncology
Jorge D. Oldan, Jennifer A. Schroeder, Jean H. Hoffman-Censits, et al.
PET Clinics (2024) Vol. 19, Iss. 2, pp. 197-206
Closed Access | Times Cited: 3
Jorge D. Oldan, Jennifer A. Schroeder, Jean H. Hoffman-Censits, et al.
PET Clinics (2024) Vol. 19, Iss. 2, pp. 197-206
Closed Access | Times Cited: 3
Total Body PET/CT: A Role in Drug Development?
Xiangxi Meng, Xiangxing Kong, Runze Wu, et al.
Seminars in Nuclear Medicine (2024)
Closed Access | Times Cited: 3
Xiangxi Meng, Xiangxing Kong, Runze Wu, et al.
Seminars in Nuclear Medicine (2024)
Closed Access | Times Cited: 3
Advances in PET/CT Imaging for Breast Cancer
Dorine de Jong, Elise Desperito, Karine A. Al Feghali, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 13, pp. 4537-4537
Open Access | Times Cited: 9
Dorine de Jong, Elise Desperito, Karine A. Al Feghali, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 13, pp. 4537-4537
Open Access | Times Cited: 9
Effects of PEGylation on Imaging Contrast of 68Ga-Labeled Bicyclic Peptide PET Probes Targeting Nectin-4
Qiang Wan, Hongmei Yuan, Ping Cai, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 9, pp. 4430-4440
Closed Access | Times Cited: 2
Qiang Wan, Hongmei Yuan, Ping Cai, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 9, pp. 4430-4440
Closed Access | Times Cited: 2
Nectin-4 Positivity in Genitourinary Malignancies: A Systematic Review
Emanuele Crupi, Tiago Costa de Pádua, Laura Marandino, et al.
JCO Precision Oncology (2024), Iss. 8
Closed Access | Times Cited: 2
Emanuele Crupi, Tiago Costa de Pádua, Laura Marandino, et al.
JCO Precision Oncology (2024), Iss. 8
Closed Access | Times Cited: 2
Inspired by novel radiopharmaceuticals: Rush hour of nuclear medicine
Yang Liu, Yanan Ren, Yan Cui, et al.
Chinese Journal of Cancer Research (2023) Vol. 35, Iss. 5, pp. 470-482
Open Access | Times Cited: 6
Yang Liu, Yanan Ren, Yan Cui, et al.
Chinese Journal of Cancer Research (2023) Vol. 35, Iss. 5, pp. 470-482
Open Access | Times Cited: 6